ATLASKraneShares MSCI All China Health Care Index ETF (KURE): outlook, holdings and fees
KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund and is managed by KraneShares. The expense ratio is 0.64% and the yield is 3.67%. The ten largest holdings are 49% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on KURE
| Last price | $17.49 (-0.7%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 51% |
| Likely 1-month range (50%) | $16.71 – $18.40 |
| Normal 1-day range (±1σ) | ±1.6% |
| Distribution yield | 3.67% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
KURE fund facts
| Issuer | KraneShares |
|---|---|
| Theme | Healthcare |
| Assets under management | $113M |
| Expense ratio | 0.64% |
| Number of holdings | 40 |
| Portfolio turnover | 32% |
| Inception | Jan 31, 2018 |
| Exchange | NYSE |
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
KURE top holdings
| Holding | Sector | Weight |
|---|---|---|
| Innovent Biologics Inc 1801 | Healthcare | 8.38% |
| WuXi Biologics 2269 | Healthcare | 7.74% |
| WuXi AppTec Co Ltd 603259 | Healthcare | 5.72% |
| Akeso Inc 9926 | Healthcare | 4.70% |
| Jiangsu Hengrui Medicine Co Ltd 600276 | Healthcare | 4.39% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760 | Healthcare | 4.18% |
| Sino Biopharmaceutical Ltd 1177 | Healthcare | 3.74% |
| CSPC Pharmaceutical Group Ltd 1093 | Healthcare | 3.66% |
| Genscript Biotech Corp 1548 | Healthcare | 3.33% |
| WuXi AppTec Co Ltd H 2359 | Healthcare | 3.34% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
KURE sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 99.1% |
| Consumer Defensive | 0.9% |
By region: Asia Emerging 79.1%, North America 17.0%, Asia Developed 3.8%.
KURE returns and risk
| Year to date | +9.1% |
|---|---|
| 1 year | -9.6% |
| 3 years (annualised) | +3.6% |
| 5 years (annualised) | -9.3% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 26.5% |
| Sharpe ratio (3 years) | 0.13 |
Past returns do not guarantee future results.
KURE: frequently asked questions
What does KURE invest in?
KraneShares MSCI All China Health Care Index ETF invests in a portfolio of securities. Its largest holdings are Innovent Biologics Inc (8.4%), WuXi Biologics (7.7%), WuXi AppTec Co Ltd (5.7%), Akeso Inc (4.7%), Jiangsu Hengrui Medicine Co Ltd (4.4%).
What is the KURE expense ratio?
0.64% a year: about $64.00 for every $10,000 invested.
What is the KURE dividend yield?
3.67%. ATLAS does not hold the exact distribution dates for ETFs.
Will KURE go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 51%, with a likely range (50%) of $16.71 to $18.40 from $17.49 today. It is a probability, not a prediction.
How has KURE performed?
Year to date +9.1%, one year -9.6%, three years +3.6% a year, five years -9.3% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
Educational information, not investment advice. Disclaimer